NCT05371847View on ClinicalTrials.gov

Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Breast Cancer
Interventions
OTHER

assessment for upper limb dysfunction

clinical assessments and questionnaires

OTHER

retest assessment

For the test-retest reliability testing, participants will be invited to have an additional appointment approximately 1 week after the main assessment.

Trial Locations (1)

3000

RECRUITING

Universitair Ziekenhuis Leuven, Leuven

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Vrije Universiteit Brussel

OTHER

lead

KU Leuven

OTHER